Press Releases

Date Title and Summary Additional Formats
Toggle Summary Radius Health to Present at Cowen 40th Annual Healthcare Conference
WALTHAM, Mass. , March 03, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland , President & CEO and Pepe Carmona , CFO will present a corporate update at the Cowen 40 th Annual Healthcare Conference in Boston at 08:40 a.m.
View HTML
Toggle Summary Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results
TYMLOS ® U.S. net sales grew to $56 million in the fourth quarter of 2019,  totaling $173M for full-year 2019, exceeding the Company’s guidance of $168 to 172M TYMLOS exited 2019 with majority share in new patients 1 , on track for market leadership in 2020 2020 TYMLOS U.S.
View HTML
Toggle Summary Radius Health to Announce Fourth Quarter and Full Year 2019 Financial Results, Host Conference Call and Live Webcast on Thursday, February 27, 2020
WALTHAM, Mass. , Feb. 13, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter and full year 2019 financial results on Thursday, February 27, 2020 . The Company will host a conference call and live audio webcast at 8:00 a.m.
View HTML
Toggle Summary Radius Health to Present at 9th Annual SVB Leerink Partners Global Healthcare Conference
WALTHAM, Mass. , Feb. 13, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President & CEO and Pepe Carmona , CFO will present a corporate update at the 9 th Annual SVB Leerink Partners Global Healthcare Conference at 10:30 a.m.
View HTML
Toggle Summary Radius Exceeds 2019 Financial Guidance and Provides Business Update at the 38th Annual J.P. Morgan Healthcare Conference
Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M . TYMLOS exits 2019 with 52% market share in new patients 1 , on track for market leadership in 2020. Radius delivers strong year-end balance sheet with $160M cash 2 balance and expects to achieve profitability
View HTML
Toggle Summary Radius Health to Present at the 38th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that its senior executive management team will present a corporate update at the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 11:30 am PST at the Westin St.
View HTML
Toggle Summary Radius Health Announces Scientific Presentations at 2019 San Antonio Breast Cancer Symposium (SABCS)
WALTHAM, Mass. , Dec. 06, 2019 (GLOBE NEWSWIRE) -- Radius Health , Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced its scientific presentations on elacestrant and RAD140 at the upcoming 2019 San Antonio Breast Cancer Symposium, which will take place from December 10 – 14 in San
View HTML
Toggle Summary Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass. , Dec. 02, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Compensation Committee of the Company’s Board of Directors granted a new employee an option to purchase 50,000 shares of the Company’s common stock with a per
View HTML
Toggle Summary Radius Health to Present at Jefferies 2019 Global Healthcare Conference in London
WALTHAM, Mass. , Nov. 15, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Hoeiland, President and CEO of the Company, will present a corporate update at the Jefferies 2019 Global Healthcare Conference in London, United Kingdom on Wednesday, November 20, 2019
View HTML
Toggle Summary Radius Health Announces Third Quarter 2019 Results and Corporate Update
TYMLOS U.S. net sales grew to $47M and is capturing half of anabolic new patient starts 1 Guidance for FY 2019 sales increased to $168-$172M (vs. $165-$170M prior) and year-end cash, cash equivalents and investments balance increased to over $130M (vs.
View HTML